Zwitter, M., Rajer, M., Stanic, K., Vrankar, M., Doma, A., Cuderman, A., . . . Kovac, V. (2016). Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations. Cancer Biol Ther.
Citação norma ChicagoZwitter, Matjaz, Mirjana Rajer, Karmen Stanic, Martina Vrankar, Andrej Doma, Anka Cuderman, Marko Grmek, Izidor Kern, and Viljem Kovac. "Intercalated Chemotherapy and Erlotinib for Non-small Cell Lung Cancer (NSCLC) With Activating Epidermal Growth Factor Receptor (EGFR) Mutations." Cancer Biol Ther 2016.
ציטוט MLAZwitter, Matjaz, et al. "Intercalated Chemotherapy and Erlotinib for Non-small Cell Lung Cancer (NSCLC) With Activating Epidermal Growth Factor Receptor (EGFR) Mutations." Cancer Biol Ther 2016.